India's pharmaceutical sector is widely expected to miss its 2030 sales target, as a combination of US import tariffs on generic drugs and prolonged shipping disruptions weigh on export momentum.…
India's central drug regulator is betting on digital technology to speed up drug approvals and sharpen oversight. The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the…
Indian drugmakers are pushing deeper into the United States biologics market. Dr. Reddy's is reported by multiple financial media outlets in early August 2026 to have secured approval from the…
India's drug regulator is going digital. In late July 2026, the Drugs Controller General of India (DCGI) confirmed that the Central Drugs Standard Control Organisation (CDSCO) is piloting artificial intelligence…